OPKO Health Return on Tangible Equity 2012-2025 | OPK
Current and historical return on tangible equity values for OPKO Health (OPK) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| OPKO Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.18B | $0.29B | -69.97% |
| 2025-06-30 | $-0.18B | $0.26B | -73.07% |
| 2025-03-31 | $-0.04B | $0.27B | -16.99% |
| 2024-12-31 | $-0.05B | $0.22B | -30.55% |
| 2024-09-30 | $-0.13B | $0.23B | -101.33% |
| 2024-06-30 | $-0.24B | $0.21B | -247.57% |
| 2024-03-31 | $-0.25B | $0.04B | -295.60% |
| 2023-12-31 | $-0.19B | $0.05B | -167.11% |
| 2023-09-30 | $-0.21B | $0.09B | -153.05% |
| 2023-06-30 | $-0.21B | $0.16B | -124.96% |
| 2023-03-31 | $-0.29B | $0.15B | -147.16% |
| 2022-12-31 | $-0.33B | $0.14B | -155.27% |
| 2022-09-30 | $-0.32B | $0.22B | -82.02% |
| 2022-06-30 | $-0.20B | $0.28B | -40.75% |
| 2022-03-31 | $-0.12B | $0.21B | -19.96% |
| 2021-12-31 | $-0.03B | $0.84B | -4.47% |
| 2021-09-30 | $0.08B | $0.66B | 12.90% |
| 2021-06-30 | $0.07B | $0.62B | 13.14% |
| 2021-03-31 | $0.12B | $0.56B | 24.69% |
| 2020-12-31 | $0.03B | $0.52B | 7.04% |
| 2020-09-30 | $-0.11B | $0.46B | -27.23% |
| 2020-06-30 | $-0.20B | $0.42B | -50.38% |
| 2020-03-31 | $-0.29B | $0.37B | -73.71% |
| 2019-12-31 | $-0.32B | $0.41B | -74.51% |
| 2019-09-30 | $-0.28B | $0.38B | -63.63% |
| 2019-06-30 | $-0.25B | $0.43B | -53.96% |
| 2019-03-31 | $-0.19B | $0.47B | -41.61% |
| 2018-12-31 | $-0.15B | $0.48B | -33.91% |
| 2018-09-30 | $-0.30B | $0.44B | -66.63% |
| 2018-06-30 | $-0.30B | $0.45B | -61.03% |
| 2018-03-31 | $-0.31B | $0.44B | -57.04% |
| 2017-12-31 | $-0.31B | $0.44B | -50.58% |
| 2017-09-30 | $-0.13B | $0.66B | -19.23% |
| 2017-06-30 | $-0.10B | $0.66B | -16.22% |
| 2017-03-31 | $-0.07B | $0.65B | -11.74% |
| 2016-12-31 | $-0.05B | $0.62B | -8.03% |
| 2016-09-30 | $-0.01B | $0.62B | -1.52% |
| 2016-06-30 | $0.13B | $0.52B | 23.39% |
| 2016-03-31 | $0.08B | $0.63B | 13.54% |
| 2015-12-31 | $-0.03B | $0.60B | -5.66% |
| 2015-09-30 | $-0.09B | $0.55B | -16.43% |
| 2015-06-30 | $-0.26B | $0.44B | -49.46% |
| 2015-03-31 | $-0.24B | $0.53B | -42.55% |
| 2014-12-31 | $-0.17B | $0.55B | -29.95% |
| 2014-09-30 | $-0.14B | $0.60B | -23.45% |
| 2014-06-30 | $-0.15B | $0.62B | -25.67% |
| 2014-03-31 | $-0.13B | $0.53B | -27.41% |
| 2013-12-31 | $-0.12B | $0.57B | -31.81% |
| 2013-09-30 | $-0.10B | $0.57B | -44.59% |
| 2013-06-30 | $-0.05B | $0.15B | -58.68% |
| 2013-03-31 | $-0.06B | $0.16B | -104.59% |
| 2012-12-31 | $-0.03B | $0.01B | -120.39% |
| 2012-09-30 | $-0.01B | $0.01B | -36.09% |
| 2012-06-30 | $-0.01B | $0.04B | -21.89% |
| 2012-03-31 | $-0.01B | $0.04B | -9.52% |
| 2011-12-31 | $0.00B | $0.04B | -3.87% |
| 2011-09-30 | $-0.02B | $0.08B | -31.88% |
| 2011-06-30 | $-0.02B | $0.09B | -42.42% |
| 2011-03-31 | $-0.02B | $0.10B | -60.27% |
| 2010-12-31 | $-0.02B | $0.01B | -96.55% |
| 2010-09-30 | $-0.03B | $0.00B | -133.33% |
| 2010-06-30 | $-0.03B | $0.03B | -88.89% |
| 2010-03-31 | $-0.03B | $0.04B | -87.32% |
| 2009-12-31 | $-0.04B | $0.01B | -159.09% |
| 2009-09-30 | $-0.04B | $0.06B | -205.88% |
| 2009-06-30 | $-0.03B | $0.03B | -1200.00% |
| 2009-03-31 | $-0.04B | $-0.02B | 524.14% |
| 2008-12-31 | $-0.04B | $-0.01B | 1066.67% |
| 2008-09-30 | $-0.04B | $0.00B | 15600.00% |
| 2008-06-30 | $-0.03B | $-0.01B | 2400.00% |
| 2008-03-31 | $-0.03B | $0.00B | -2400.00% |
| 2007-12-31 | $-0.27B | $0.01B | -8276.92% |
| 2007-09-30 | $-0.01B | $0.00B | -666.67% |
| 2007-06-30 | $-0.01B | $0.00B | -258.82% |
| 2007-03-31 | $0.00B | $0.01B | 0.00% |
| 2006-12-31 | $0.00B | $0.00B | -15.38% |
| 2006-09-30 | $-0.25B | $0.01B | -2868.57% |
| 2006-06-30 | $-0.25B | $0.01B | -2777.78% |
| 2006-03-31 | $-0.25B | $0.01B | -2777.78% |
| 2005-12-31 | $0.00B | $0.01B | 0.00% |
| 2005-09-30 | $0.00B | $0.01B | 0.00% |
| 2005-06-30 | $0.00B | $0.01B | -10.81% |
| 2005-03-31 | $0.00B | $0.01B | -21.62% |
| 2004-12-31 | $0.00B | $0.01B | -21.05% |
| 2004-09-30 | $0.00B | $0.01B | -42.11% |
| 2004-06-30 | $-0.01B | $0.01B | -58.54% |
| 2004-03-31 | $-0.01B | $0.01B | -62.22% |
| 2003-12-31 | $-0.01B | $0.01B | -56.00% |
| 2003-09-30 | $-0.01B | $0.01B | -64.29% |
| 2003-06-30 | $-0.01B | $0.01B | -62.50% |
| 2003-03-31 | $-0.01B | $0.02B | -54.05% |
| 2002-12-31 | $-0.01B | $0.02B | -53.01% |
| 2002-09-30 | $-0.01B | $0.02B | -38.71% |
| 2002-06-30 | $-0.01B | $0.02B | -36.00% |
| 2002-03-31 | $-0.01B | $0.02B | -37.38% |
| 2001-12-31 | $-0.01B | $0.03B | -34.48% |
| 2001-09-30 | $-0.01B | $0.03B | -28.80% |
| 2001-06-30 | $-0.01B | $0.03B | -23.88% |
| 2001-03-31 | $-0.01B | $0.03B | -16.90% |
| 2000-12-31 | $-0.01B | $0.04B | -19.20% |
| 2000-09-30 | $-0.01B | $0.04B | -26.09% |
| 2000-06-30 | $-0.01B | $0.04B | -33.90% |
| 2000-03-31 | $-0.01B | $0.02B | -80.00% |
| 1999-12-31 | $0.00B | $0.00B | -114.29% |
| 1999-09-30 | $0.00B | $0.00B | -94.12% |
| 1999-06-30 | $0.00B | $0.00B | -80.00% |
| 1999-03-31 | $0.00B | $0.01B | -52.17% |
| 1998-12-31 | $0.00B | $0.01B | -66.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.944B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |